Navigation Links
MGC Diagnostics Corporation Appoints Wesley W. Winnekins as Executive Vice President, Finance and Corporate Development; Winnekins will also serve as Chief Financial Officer

SAINT PAUL, Minn., Feb. 4, 2013 /PRNewswire/ -- MGC Diagnostics Corporation (NASDAQ: MGCD) (formerly Angeion Corporation), a global medical technology company, today announced the appointment of Wesley W. Winnekins as Executive Vice President, Finance and Corporate Development, effective immediately.  Mr. Winnekins will also serve as the Company's Chief Financial Officer.


In connection with the appointment of Mr. Winnekins, the Company will be entering into a Separation Agreement with the prior Chief Financial Officer Robert M. Wolf .  Mr. Wolf's last day as Chief Financial Officer was January 31, 2013.

Prior to joining MGC Diagnostics, Mr. Winnekins served as Chief Financial Officer of Snap Fitness, Inc. a multi-national franchisor of 24/7 express fitness clubs from February 2011 to October 2012.  Prior to that, he was employed by Health Fitness Corporation from February 2001 to December 2010, serving as Executive Vice President, Finance and Operations from March 2010 to December 2010, and as Chief Financial Officer and Treasurer from February 2001 to February 2010.  Prior to working at Health Fitness Corporation, Mr. Winnekins served in finance and management capacities for several public and private companies, including health and fitness companies, from October 1987 to February 2001.  From May 1985 to October 1987, Mr. Winnekins served in the audit practice at Arthur Andersen. Mr. Winnekins received a Bachelor's in Business Administration with a major in Accounting from Iowa State University and has passed the CPA exam.

Gregg O. Lehman , Ph.D., president and chief executive officer of MGC Diagnostics, said, "I am pleased to have Wes Winnekins join our management team. He is a proven public company financial executive with a broad skill set that includes SEC financial reporting, mergers and acquisitions, and a highly developed network of professionals that spans a career of more than 25 years. These credentials will make Wes an invaluable partner as we continue to execute our strategic plan."

"I want to express my appreciation to Rob Wolf who has left the Company to pursue other opportunities," continued Dr. Lehman. "Rob has been a valuable member of our leadership team and has provided stability and solid performance during his tenure as CFO.  I am grateful for his contributions and wish him the best in the future."

About MGC DiagnosticsMGC Diagnostics Corporation (NASDAQ: MGCD), (formerly Angeion Corporation), is a global medical technology company dedicated to cardiorespiratory health solutions. MGC Diagnostics develops, manufactures and markets non-invasive diagnostic systems. This portfolio of products provide solutions for disease detection, integrated care, and wellness across the spectrum of cardiorespiratory healthcare. The Company's products are sold internationally through distributors and in the United States through a direct sales force targeting heart and lung specialists located in hospitals, university-based medical centers, medical clinics, physicians' offices, pharmaceutical companies, medical device manufacturers, and clinical research organizations (CROs). For more information about MGC Diagnostics, visit

Cautionary Statement Regarding Forward Looking StatementsFrom time to time, in reports filed with the Securities and Exchange Commission, in press releases, and in other communications to shareholders or the investing public, MGC Diagnostics Corporation may make forward−looking statements concerning possible or anticipated future financial performance, business activities or plans that include the words "believes," "expects," "anticipates," "intends" or similar expressions. For these forward−looking statements, the Company claims the protection of the safe harbor for forward−looking statements contained in federal securities laws.  These forward−looking statements are subject to a number of factors, risks and uncertainties, including those disclosed in our periodic filings with the SEC, that could cause actual performance, activities or plans after the date the statements are made to differ significantly from those indicated in the forward−looking statements. For a list of these factors¸ see the sections entitled "Risk Factors" and "Cautionary Note Regarding Forward Looking Statements," in the Company's Form 10-K for the year ended October 31, 2012, and any updates in subsequent filings on Form 10-Q or Form 8-K under the Securities Exchange Act of 1934.Contact:Gregg O. Lehman, Ph.D.

Joe Dorame, Robert Blum, Joe DiazMGC Diagnostics Corporation

Lytham Partners, LLCChief Executive Officer 

(602) 889-9700(651) 484-4874

SOURCE MGC Diagnostics Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Strand Diagnostics appoints new President
3. Johnson & Johnson Presents Growth Strategies for Medical Devices & Diagnostics Segment
4. Roche Diagnostics Named to FORTUNE magazines 2013 list of "100 Best Companies to Work For"
5. MGC Diagnostics Corporation Reports Fourth Quarter and Fiscal Year 2012 Operating Results
6. Cardiology Point of Care Diagnostics: Products, players & outlook to 2017
7. The Complete Guide to Companion Diagnostics: Market Environment Products and Companies
8. Increasing Prevalence of Heart Disease Drives Growth of Cardiac Biomarkers Diagnostics Market, Says Frost & Sullivan
9. MGC Diagnostics Corporation to Report Fourth Quarter and Fiscal Year 2012 Financial Results on Wednesday, December 19, 2012
10. Artemis Diagnostics awarded two grants from Technology Strategy Board to develop cancer imaging technology
11. Global Market for Molecular Diagnostics to Exceed $10.7 Billion by 2018, Regenerative Medicine to Top $4.4 Billion
Post Your Comments:
(Date:11/26/2015)... , November 26, 2015 3D ... by 2022, according to a new report by Grand View ... Kidney Disease (CKD) which demands kidney transplantation is expected to ... cost effective substitute for organ transplantation. --> 3D ... by 2022, according to a new report by Grand View ...
(Date:11/26/2015)... , November 26, 2015 ... Juntendo universitetssjukhus ser potential att använda ... magnetresonansbilder (MR-bilder) för patienter med multipel ... ett forskningsavtal med SyntheticMR AB för att ... forskningsprojekt på sjukhuset. Med SyMRI kan man ...
(Date:11/26/2015)... 26, 2015 Research and Markets ( ... "2016 Future Horizons and Growth Strategies in ... Shares, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities" ... --> --> This new ... Italian therapeutic drug monitoring market, including emerging tests, ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... 25, 2015 , ... Wimbledon Health Partners, the industry leader ... Athletics Facebook page to educate the public, parents and school athletic departments ... people under the age of 25 die from sudden cardiac arrest every year. ...
(Date:11/25/2015)... ... November 25, 2015 , ... Smiles by Stevens is pleased ... moderate facial wrinkling. While many patients are aware of the benefits of Botox® in ... delivers to those suffering with discomfort, soreness, and pain as a result of Jaw ...
(Date:11/25/2015)... ... November 25, 2015 , ... Brillianteen, ... friendships, and learning in its 65th Anniversary Brillianteen Revue, scheduled for March 4-6, ... , For 65 years, Brillianteen has been a treasured tradition for numerous families ...
(Date:11/25/2015)... ... 2015 , ... Today, Mothers Against Drunk Driving (MADD) learned that ... for the first time since 2011. In 2014, there were 9,967 fatalities involving an ... the National Highway Traffic Safety Administration (NHTSA), 32,675 people were killed in traffic crashes ...
(Date:11/25/2015)... ... November 25, 2015 , ... "When I underwent ... bras were incredibly uncomfortable," said an inventor from Bronx, N.Y. "In order to ... the patent-pending RECOVERY BRA for added comfort and support. The bra is easier ...
Breaking Medicine News(10 mins):